Newswise Feature Channel: Stem Cells

Cedars-Sinai, UCSF Experts Steer the Development of Stem Cells to Regenerate and Repair Organs

Cedars-Sinai — Thu, 19 Dec 2024 21:00:34 EST

Investigators from Cedars-Sinai and the University of California, San Francisco (UCSF) have identified a new way to deliver instructions that tell stem cells to grow into specific bodily structures, a critical step in eventually regenerating and repairing tissues and organs.

MD Anderson Research Highlights for December 18, 2024

University of Texas MD Anderson Cancer Center — Wed, 18 Dec 2024 22:15:07 EST

The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Neural Stem Cell Transplantation Shows Promise for Treating Chronic Spinal Cord Injury

University of California San Diego — Tue, 17 Dec 2024 09:00:05 EST

UChicago Medicine Receives $2.8 Million to Empower Underrepresented Students in Cancer Research

University of Chicago Medical Center — Fri, 13 Dec 2024 17:40:18 EST

The federally funded pathway programs strive to increase diversity and equity in the cancer research field, a key strategy to reduce health disparities in the Chicagoland area and across the country.

UTSW Research: Python Guts, Emergency Room Visits, and More

UT Southwestern Medical Center — Thu, 12 Dec 2024 21:00:25 EST

Regeneration insights from snake intestines / Understanding why cancer patients visit the ED / How burr holes affect transcranial direct current stimulation

Using Stem-Cell Transplants to Treat Blindness

Universite de Montreal — Tue, 10 Dec 2024 12:00:24 EST

UdeM scientists have developed a method to create retinal transplants from stem cells, and with them, blind mini-pigs have showed signs of restored vision, a promising development for humans, as well.

Two Case Western Reserve University faculty members honored as Fellows of the National Academy of Inventors

Case Western Reserve University — Tue, 10 Dec 2024 10:00:00 EST

Polymer scientist Gary E. Wnek and stem-cell biologist Arnold Caplan have been named Fellows of the National Academy of Inventors (NAI), the highest professional distinction awarded solely to inventors.

ASH: Triplet combination regimens demonstrate high response rates in multiple leukemias

University of Texas MD Anderson Cancer Center — Mon, 09 Dec 2024 20:00:38 EST

Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated significant positive results from novel triplet therapies in the treatment of relapsed or refractory and newly diagnosed leukemias. The results were presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition. More information on all ASH Annual Meeting content from MD Anderson can be found at MDAnderson.org/ASH.

Multi-Center Study Shows Education Level, Income Impact Access to Stem Cell Transplantation for Acute Myeloid Leukemia Patients

Fred Hutchinson Cancer Center — Sun, 08 Dec 2024 11:10:31 EST

Patients with acute myeloid leukemia who have lower education levels and lower income are less likely to receive a allogeneic hematopoietic stem cell transplant for acute myeloid, however, if they can access the treatment, are equally likely to benefit from transplant as patients with more education and higher income, according to a new study from Fred Hutch Cancer Center presented at the annual meeting of the American Society of Hematology.

Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes

University of California San Diego — Thu, 05 Dec 2024 15:50:55 EST

New Drug Tested to Reduce Side Effect of 'Half-Matched' Stem Cell Transplants

Washington University in St. Louis — Thu, 05 Dec 2024 14:35:41 EST

Stem cell transplantation is used to treat several types of blood cancers, but carries the risk of a life-threatening side effect called graft-versus-host disease. Results from a clinical trial conducted by researchers at WashU Medicine showed adding the investigational drug itacitinib to standard care for "half-matched" stem cell transplantation may reduce rates of the disease, in which the donor's stem cells attack the patient's healthy tissues.

How Breast Cancer Cells Survive in Bone Marrow After Remission

Michigan Medicine - University of Michigan — Wed, 04 Dec 2024 14:00:55 EST

A study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.

Yale Study: CHIP Is an Independent Risk Factor for ICI Myocarditis

Yale School of Medicine — Tue, 03 Dec 2024 09:40:38 EST

ASH: Gene Therapy for Rare Genetic Disorder, Molecular Insights Into Leukemia Growth and More

University of California, Los Angeles (UCLA), Health Sciences — Mon, 02 Dec 2024 13:40:34 EST

Wistar Institute Scientists Identify Important Factor in Neural Development

Wistar Institute — Tue, 26 Nov 2024 17:00:00 EST

The Wistar Institute's Dr. Alessandro Gardini and his lab have published their new paper, "The enhancer module of integrator controls cell identity and early neural fate commitment," in the journal Nature Cell Biology.

UNC Scientists Discover New Details of Gene Regulation

University of North Carolina School of Medicine — Tue, 26 Nov 2024 12:20:51 EST

Genetic researchers at the UNC School of Medicine have identified a key focal point in the biological processes that control cell identity and can lead to disease when mutated.

Potential of Ginsenoside Rg1 to Treat Aplastic Anemia via Mitogen Activated Protein Kinase Pathway in Cyclophosphamide-Induced Myelosuppression Mouse Model

World Journal of Stem Cells — Tue, 26 Nov 2024 12:00:44 EST

Aplastic anemia (AA) is a rare but serious condition in which the bone marrow fails to produce sufficient new blood cells, leading to fatigue, increased susceptibility to infection, and uncontrolled bleeding. In this editorial, we review an

Refining Adipose-Derived Stem Cell Isolation for Optimal Regenerative Therapy

World Journal of Stem Cells — Tue, 26 Nov 2024 12:00:42 EST

This article highlights the importance of optimizing the techniques used for isolating stromal vascular fraction cells from adipose tissue. Furthermore, by presenting key findings from the literature, it clarifies the effects of refined tec

Resilience and Challenges: Evaluating the Impact of Stress Conditions on Mesenchymal Stem Cells Across Different Passages

World Journal of Stem Cells — Tue, 26 Nov 2024 12:00:37 EST

This article discussed a study by Almahasneh et al, which investigated how high glucose and severe hypoxia affected mesenchymal stem cells (MSCs) at different passages. This research provides insights into the resilience of higher-passage M

Melatonin-Based Priming of Stem Cells to Alleviate Oxidative Stress

World Journal of Stem Cells — Tue, 26 Nov 2024 12:00:35 EST

Stem cell expansion in vitro and transplantation in the cytokine-rich proinflammatory milieu in the injured tissue generate immense oxidative stress that interferes with the cells' survival, stemness, and repairability. Stem cell priming